This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $500 | Check With Us |
200mg | $750 | Check With Us |
500mg | $1135 | Check With Us |
Cat #: V12088 CAS #: 59729-37-2 Purity ≥ 99%
Description: Fexinidazole (Hoe239; Hoe-239) is a novel, potent and nitroimidazole-based antiparasitic agent that has been approved in 2021 by FDA as the first all-oral medication to treat African trypanosomiasis caused by Trypanosoma brucei gambiense.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 279.31 |
---|---|
Molecular Formula | C12H13N3O3S |
CAS No. | 59729-37-2 |
Protocol | In Vitro | Fexinidazole (HOE 239) has two principal metabolites, sulfoxide and sulfone. They have shown trypanocidal activity in vitro with IC50s of 0.7-3.3 μM (0.2-0.9 μg/ml) range against all parasite strains tested |
---|---|---|
In Vivo | Fexinidazole (HOE 239; 20-50 mg/kg/day of IP or 25-100 mg/kg/day of PO; four consecutive days) has antitrypanosomal activities[ | |
Animal model | Adult female NMRI mice weighing between 20 and 25 g T. b. rhodesiense[1] | |
Dosages | 20, 50 mg/kg (IP) or 25, 50, 100 mg/kg (PO) | |
Administration | IP or PO; daily; four consecutive days |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 3.5803 mL | 17.9013 mL | 35.8025 mL | 71.6050 mL |
5mM | 0.7161 mL | 3.5803 mL | 7.1605 mL | 14.3210 mL |
10mM | 0.3580 mL | 1.7901 mL | 3.5803 mL | 7.1605 mL |
20mM | 0.1790 mL | 0.8951 mL | 1.7901 mL | 3.5803 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.